Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (343)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bursch, W.
Right arrow Articles by Schulte-Hermann, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bursch, W.
Right arrow Articles by Schulte-Hermann, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1984 Oxford University Press

other

Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters

W. Bursch , B. Lauer , I. Timmermann-Trosiener , G. Barthel , J. Schuppler 1 and R. Schulte-Hermann 

Institut für Toxikologie und Pharmakologie der Philipps-Universitat in Marburg/Lahn Pilgrimstein 2, D-3550 Marburg a.d. Lahn
1Department für Experimentelle Toxikologie, Schering AG 1000 Berlin 65, FRG

Numerous drugs, hormones and environmental pollutants induce liver growth by hypertrophy and/or hyperplasia, and promote preferential growth of putative preneoplastic foci in the liver. In the present study the regression of hyperplasia after cessation of inducer/promoter treatment was studied in normal liver and in liver foci. High doses of cyproterone acetate (CPA), a synthetic sex steroid, were administered to rats and produced a doubling of liver size; after cessation of treatment liver size declined, and 27% of the total liver DNA disappeared within 6 days. In histological sections from the involuting liver no necroses, but numerous apoptotic bodies (ABs) were found; retreatment with CPA interrupted the formation of ABs. These findings suggest that elimination of excess liver DNA after cessation of CPA treatment is due to controlled cell death by apoptosis. In a further series of experiments putative preneoplastic foci were produced by a single dose of N-nitrosomorpholine and subsequently stimulated to grow by 10 or 28 weeks of phenobarbital (PB) treatment. After withdrawal of PB numerous ABs were present in normal liver and in the foci; in both, retreatment with PB decreased the appearance of ABs. It appears that inhibition of cell death by PB may contribute to tumor promotion. Under all conditions tested more ABs were found in the foci than in non-focal parts of the liver, suggesting an enhanced cell turnover in foci. The apparent sensitivity of foci to mechanisms controlling cell death might eventually provide a means for elimination of preneoplastic lesions.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
RadiologyHome page
M. Tubiana, L. E. Feinendegen, C. Yang, and J. M. Kaminski
The Linear No-Threshold Relationship Is Inconsistent with Radiation Biologic and Experimental Data
Radiology, April 1, 2009; 251(1): 13 - 22.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Huang, J. Zhang, M. Washington, J. Liu, J. M. Parant, G. Lozano, and D. D. Moore
Xenobiotic Stress Induces Hepatomegaly and Liver Tumors via the Nuclear Receptor Constitutive Androstane Receptor
Mol. Endocrinol., June 1, 2005; 19(6): 1646 - 1653.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Bursch, M. Chabicovsky, U. Wastl, B. Grasl-Kraupp, K. Bukowska, H. Taper, and R. Schulte-Hermann
Apoptosis in Stages of Mouse Hepatocarcinogenesis: Failure to Counterbalance Cell Proliferation and to Account for Strain Differences in Tumor Susceptibility
Toxicol. Sci., May 1, 2005; 85(1): 515 - 529.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
W. Bursch, U. Wastl, K. Hufnagl, and R. Schulte-Hermann
No Increase of Apoptosis in Regressing Mouse Liver after Withdrawal of Growth Stimuli or Food Restriction
Toxicol. Sci., May 1, 2005; 85(1): 507 - 514.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. F. Calvisi, S. Ladu, V. M. Factor, and S. S. Thorgeirsson
Activation of {beta}-catenin provides proliferative and invasive advantages in c-myc/TGF-{alpha} hepatocarcinogenesis promoted by phenobarbital
Carcinogenesis, June 1, 2004; 25(6): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Vejda, N. Erlach, B. Peter, C. Drucker, W. Rossmanith, J. Pohl, R. Schulte-Hermann, and M. Grusch
Expression of activins C and E induces apoptosis in human and rat hepatoma cells
Carcinogenesis, November 1, 2003; 24(11): 1801 - 1809.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. Chen, M. Delannoy, S. Odwin, P. He, M. A. Trush, and J. D. Yager
Enhanced Mitochondrial Gene Transcript, ATP, Bcl-2 Protein Levels, and Altered Glutathione Distribution in Ethinyl Estradiol-Treated Cultured Female Rat Hepatocytes
Toxicol. Sci., October 1, 2003; 75(2): 271 - 278.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
I. Silins, M. Nordstrand, J. Hogberg, and U. Stenius
Sphingolipids suppress preneoplastic rat hepatocytes in vitro and in vivo
Carcinogenesis, June 1, 2003; 24(6): 1077 - 1083.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. A. Canuto, G. Muzio, M. Maggiora, A. Trombetta, G. Martinasso, R. Autelli, P. Costelli, G. Bonelli, and F. M. Baccino
Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase
J. Lipid Res., January 1, 2003; 44(1): 56 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. G. Calfee-Mason, B. T. Spear, and H. P. Glauert
Vitamin E Inhibits Hepatic NF-{kappa}B Activation in Rats Administered the Hepatic Tumor Promoter, Phenobarbital
J. Nutr., October 1, 2002; 132(10): 3178 - 3185.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Oyama, G. Shiota, H. Ito, Y. Murawaki, and H. Kawasaki
Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats
Carcinogenesis, May 1, 2002; 23(5): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
R. H. Pierce, M. E. Vail, L. Ralph, J. S. Campbell, and N. Fausto
Bcl-2 Expression Inhibits Liver Carcinogenesis and Delays the Development of Proliferating Foci
Am. J. Pathol., May 1, 2002; 160(5): 1555 - 1560.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. S. Isenberg, L. M. Kamendulis, D. C. Ackley, J. H. Smith, G. Pugh Jr., A. W. Lington, R. H. McKee, and J. E. Klaunig
Reversibility and Persistence of Di-2-ethylhexyl Phthalate (DEHP)- and Phenobarbital-Induced Hepatocellular Changes in Rodents
Toxicol. Sci., December 1, 2001; 64(2): 192 - 199.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Bohnenberger, B. Wagner, H.-J. Schmitz, and D. Schrenk
Inhibition of apoptosis in rat hepatocytes treated with `non-dioxin-like' polychlorinated biphenyls
Carcinogenesis, October 1, 2001; 22(10): 1601 - 1605.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
Do Youn Park, Soon Yeol Hwang, and Kang Suek Suh
Expression of Transforming Growth Factor (TGF)-{beta}1 and TGF-{beta} Type II Receptor in Preneoplastic Lesions During Chemical Hepatocarcinogenesis of Rats
Toxicol Pathol, August 1, 2001; 29(5): 541 - 549.
[Abstract] [PDF]


Home page
Cancer Res.Home page
S. Yang, H. Z. Lin, J. Hwang, V. P. Chacko, and A. M. Diehl
Hepatic Hyperplasia in Noncirrhotic Fatty Livers: Is Obesity-related Hepatic Steatosis a Premalignant Condition?
Cancer Res., July 1, 2001; 61(13): 5016 - 5023.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Kiba, S. Saito, K. Numata, Y. Kon, T. Mizutani, and H. Sekihara
Expression of apoptosis on rat liver by hepatic vagus hyperactivity after ventromedial hypothalamic lesioning
Am J Physiol Gastrointest Liver Physiol, May 1, 2001; 280(5): G958 - G967.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. E. Vail, R. H. Pierce, and N. Fausto
Bcl-2 Delays and Alters Hepatic Carcinogenesis Induced by Transforming Growth Factor {{alpha}}
Cancer Res., January 1, 2001; 61(2): 594 - 601.
[Abstract] [Full Text]


Home page
Hum Exp ToxicolHome page
J E Klaunig, L M Kamendulis, and Y. Xu
Epigenetic mechanisms of chemical carcinogenesis
Human and Experimental Toxicology, October 1, 2000; 19(10): 543 - 555.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
A. Low-Baselli, W. W. Huber, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note
Carcinogenesis, October 1, 2000; 21(10): 1869 - 1877.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Grasl-Kraupp, G. Luebeck, A. Wagner, A. Low-Baselli, M. de Gunst, T. Waldhor, S. Moolgavkar, and R. Schulte-Hermann
Quantitative analysis of tumor initiation in rat liver: role of cell replication and cell death (apoptosis)
Carcinogenesis, July 1, 2000; 21(7): 1411 - 1421.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Chen, M. Gokhale, B. Schofield, S. Odwin, and J. D. Yager
Inhibition of TGF-{beta}-induced apoptosis by ethinyl estradiol in cultured, precision cut rat liver slices and hepatocytes
Carcinogenesis, June 1, 2000; 21(6): 1205 - 1211.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. M. Ledda-Columbano, A. Perra, R. Loi, H. Shinozuka, and A. Columbano
Cell Proliferation Induced by Triiodothyronine in Rat Liver Is Associated with Nodule Regression and Reduction of Hepatocellular Carcinomas
Cancer Res., February 1, 2000; 60(3): 603 - 609.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
J. S. Isenberg and J. E. Klaunig
Role of the Mitochondrial Membrane Permeability Transition (MPT) in Rotenone-Induced Apoptosis in Liver Cells
Toxicol. Sci., February 1, 2000; 53(2): 340 - 351.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G.M. Ledda-Columbano, A. Perra, R. Piga, M. Pibiri, R. Loi, H. Shinozuka, and A. Columbano
Cell proliferation induced by 3,3',5-triiodo-L-thyronine is associated with a reduction in the number of preneoplastic hepatic lesions
Carcinogenesis, December 1, 1999; 20(12): 2299 - 2304.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
X. Lin, D. A. Levitsky, J. M. King, and T. C. Campbell
The promotion effect of anorectic drugs on aflatoxin B1-induced hepatic preneoplastic foci
Carcinogenesis, September 1, 1999; 20(9): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. A. Wood, D. S.R. Sarma, and M. C. Archer
Resistance to the promotion of glutathione S-transferase 7-7-positive liver lesions in Copenhagen rats
Carcinogenesis, July 1, 1999; 20(7): 1169 - 1175.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Tombolan, D. Renault, D. Brault, M. Guffroy, F. Perin, and V. Thybaud
Effect of mitogenic or regenerative cell proliferation on lacz mutant frequency in the liver of MutaTMMice treated with 5,9-dimethyldibenzo[c,g]carbazole
Carcinogenesis, July 1, 1999; 20(7): 1357 - 1362.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Sanders and S. S. Thorgeirsson
Phenobarbital promotes liver growth in c-myc/TGF-{alpha} transgenic mice by inducing hypertrophy and inhibiting apoptosis
Carcinogenesis, January 1, 1999; 20(1): 41 - 49.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
R. S. Mangipudy, P. S. Rao, A. Andrews, T. J. Bucci, F. A. Witzmann, and H. M. Mehendale
Dose-Dependent Modulation of Cell Death: Apoptosis Versus Necrosis in Thioacetamide Hepatotoxicity
International Journal of Toxicology, February 1, 1998; 17(2): 193 - 211.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
A. A. Constan, S. A. Benjamin, J. D. Tessari, D. C. Baker, and R. S.H. Yang
Increased Rate of Apoptosis Correlates with Hepatocellular Proliferation in Fischer-344 Rats Following Long-Term Exposure to a Mixture of Groundwater Contaminants
Toxicol Pathol, May 1, 1996; 24(3): 315 - 322.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
C. C Boyle
Divide and rule: Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations Roberts RA, Soames AR, Gill JH, James NH and Wheeldon EB Carcinogenesis 1995; 16: 1693-1698
Human and Experimental Toxicology, April 1, 1996; 15(4): 364 - 366.
[PDF]


Home page
Toxicol PatholHome page
E. B. Wheeldon, S. M. Williams, A. R. Soames, N. H. James, and R. A. Roberts
Quantitation of Apoptotic Bodies in Rat Liver by In Situ End Labelling (ISEL): Correlation with Morphology
Toxicol Pathol, May 1, 1995; 23(3): 410 - 415.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
F. Stenback, R. Gebhardt, H. Sirma, J.-M. Garbay, and G. M. Williams
Sequential Functional and Morphological Alterations During Hepatocarcinogenesis Induced in Rats by Feeding of a Low Dose of 2-Acetylaminofluorene
Toxicol Pathol, November 1, 1994; 22(6): 620 - 632.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
J. Ashby, A. Brady, C.R. Elcombe, B.M. Elliott, J. Ishmael, J. Odum, J.D. Tugwood, S. Kettle, and I.F.H. Purchase
Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis
Human and Experimental Toxicology, January 1, 1994; 13(2_suppl): S1 - S117.
[PDF]


Home page
J. Cell Sci.Home page
A. Bayly, N. French, C Dive, and R. Roberts
Non-genotoxic hepatocarcinogenesis in vitro: the FaO hepatoma line responds to peroxisome proliferators and retains the ability to undergo apoptosis
J. Cell Sci., January 2, 1993; 104(2): 307 - 315.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
F Oberhammer, G Fritsch, M Schmied, M Pavelka, D Printz, T Purchio, H Lassmann, and R Schulte-Hermann
Condensation of the chromatin at the membrane of an apoptotic nucleus is not associated with activation of an endonuclease
J. Cell Sci., January 2, 1993; 104(2): 317 - 326.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.